The success of cancer treatments have resulted in a rapid growth of survivors, providing the impetus for the oncology community to examine models of care supporting smooth transition from active treatment to survivorship care. While initially a recommendation of the Institute of Medicine, treatment summaries and survivorship care plans are now an accreditation requirement for many organizations. This article describes the implementation of an evidence based practice project designed to meet these standards while improving the knowledge and satisfaction of a population of breast cancer patients at a community-based oncology practice.
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Background
Today, an estimated 14.5 million people are survivors of cancer, and the number is steadily rising due to dramatic and rapid advances in the screening, diagnosis, and treatment of cancer. 1, 2 Breast cancer survivors are a prominent subset, accounting for 3.1 million survivors. 3 Projections are that 68% of adults with cancer are expected to be alive in 5 years, a remarkable upward trend from 1977 when the 5-year survival rate was a mere 49%. 1 Regarding breast cancer, a woman diagnosed today, has an 89% chance of being alive in 5-years, 83% in 10 years, and 78% at 15 years. 2 These expanding categories of patients, those presumed cured, and those living with cancer as a chronic disease, present a new dilemma in the paradigm of cancer care.
Oncology providers are taxed with evaluating the evidence of a rapid expansion of fasttracked chemotherapeutics, biologic agents, and immunotherapies and how to best sequence therapy. The demand to keep pace in the area of acute oncology has overshadowed the growing concerns on both ends of the spectrum of oncology care:
those who survive their disease and those who will succumb. The evaluation and implementation of care models to transfer these responsibilities to other qualified providers is a vexing challenge.
In the 2006 Institute of Medicine (IOM) Report, From Cancer Patient to Cancer
Survivors: Lost in Transition, survivorship care was described as falling short of the ideal being plagued with poor communication, fragmentation, and lack of coordination of services. Inappropriate use of services, lack of attention to late-and long-term effects, and the absence of preventive care were also cited. 4 A major limitation of their survivorship care reported by patients was insufficient communication between their oncologist and primary care provider (PCP), leading to feelings of anxiety and abandonment. 5, 6 A significant proportion of PCPs, 84%, report being uncertain of the frequency and type of surveillance tests they should be ordering. 7 Critical to monitoring survivors of cancer, is understanding the long-term side effects of the drugs and treatment modalities employed. 8 In
the 2009 Survey of Physician Attitudes Regarding the Care of
Cancer Survivors, of the 1072 PCPs who responded, only 6% were able to identify the four most common late adverse effects of the four most commonly used chemotherapeutics.
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Of the 10 recommendations for improving the care of survivors cited by the IOM, only recommendation two: "Patients completing primary treatment should be provided with a comprehensive care summary and follow-up plan… 4 " was concrete, and clearly directed to providers of oncology care. Cancer survivors have more co-morbidities and chronic health problems then the general population, and are at risk for receiving inadequate health care. 6, 12 At the conclusion of active treatment, survivors report wanting more information about their diagnosis, treatment, long-term side effects, risk of recurrence, and health maintenance. 6 As the immediate crisis of diagnosis and treatments wanes, insurance issues, occupational concerns, medical bills, and relational issues become paramount as the survivors begin the process of finding their "new normal". 6, 16 Treatment summaries and survivorship care plans (TS/SCP) were designed to synopsize the modalities used in treating a patient's cancer, and as a guideline for follow-up care. 4 The provision of a TS/SCPs and survivorship care is now a core measure of the or "very confident". 21 The benchmark for satisfaction, set at 80%, was measured using the Patient Satisfaction with Cancer-related Care (PSCC) tool. The PSCC is a validated tool of 18
item with a 5-point Likert scale where "5=Strongly Agree and 1=Strongly Disagree". It demonstrates high construct validity, internal consistency, and reliability with diverse socioeconomic and cultural populations. 22 The provider satisfaction tool was investigator developed, designed to be answered in less then three minutes, and consisted of three question using a 5-point Likert scale. The goal was for 80% of the providers to agree/strongly agree the TS/SCP was easy to understand, useful in promoting effective patient care, and provided pertinent information.
Implementation
After obtaining IRB approval, the project was guided using the John Hopkins into the EMR and a personalized survivorship visit note was generated using a standard template. The PCP and care team were mailed a brief letter of explanation, the TS/SCP, provider survey, a self-addressed stamped envelope, and a $5.00 coffee gift card. Each provider was surveyed only once.
Results
During the evaluation period, 21 women participated in the practice innovation.
Of the 26 providers who were mailed a TS/SCP, 19 (73%) returned the survey. Mean confidence in knowledge of cancer diagnosis/treatment details improved from 1.57 to 2.0.
Similarly, mean confidence scores improved from .82 to 1.85 (t=8.66) in knowledge of prevention, late/long-term effects, resources, and familiar risk for cancer (Figure 2 ).
Improvement occurred for 100% of the participants. Satisfaction was rated at 4 or better for 95% of the women and 84% of providers' agreed/strongly agreed with the elements of the survey (Figure 3 ).
Economics
An analysis of cost per visit was estimated. Average reimbursement by payer mix for a level five follow-up visit was obtained. Estimates of NP and the MA resources based on hourly rate to complete all parts of the project were subtracted from the average reimbursement. An additional $5.00 in cost was added to cover the printing of the NCI booklet. It was estimated that each visit generated approximately $25-$30 revenue.
Discussion
Arguably, there are far worse diseases then cancer, but few in which people associate so dramatically with suffering, pain, and premature death. While feeling relatively well, the newly diagnosed cancer patient is thrust into a treatment plan that is difficult, lengthy, and potentially debilitating. Throughout the diagnosis and treatment, patients have numerous contacts with multiple healthcare providers. At the completion of treatment, this frequent contact suddenly, and abruptly, ceases. As previously stated, the literature on the residual physical, emotional, and psychosocial effects of cancer and its treatment is extensive. Therefore, it is paramount for the medical community to recognize the inherit anxiety emerging at the completion of primary cancer treatment and to embrace survivorship as a significant transition point. 4 At the conclusion of adjuvant cancer treatment, the questions and concerns of the cancer patient are different. As early apprehensions around treatment side effects and impact on lifestyle fade, new issues emerge. As this EBP project demonstrated, TS/SCP and survivorship visits provide a similar impact at the end of treatment as chemotherapy teaching provides at the start. Reduction in anxiety, fear, and confusion, increase in knowledge, and improvement in self-care recommendations are all outcomes of survivorship care supported in the literature. 6, 8, [10] [11] [12] It is important to recognize aspects of this practice setting allowing the TS/SCP to be constructed at a reduced time and cost, than reported in the literature. 7, 23 By creating a standard template and populating more then 40% at the chemotherapy teaching session, the NP was able to save considerable time then might have been appreciated in practices where the TS/SCP is generated at the conclusion of treatment when the medical chart is more extensive. The NPs at this practice were familiar with the patients, their treatment, and problems they had encountered in the course of care. This proved advantageous, as the NP was able to complete the TS/SCP in an efficient manner that might not be possible who coordinated oncology treatment… 4 " cannot be understated. It is these providers who possess the knowledge to accurately set the course necessary to insure appropriate and comprehensive follow-up.
The value of a TS/SCP is more pertinent then ever as our medical system remains one of ever evolving and expanding complexity. Compliance with accreditation standards and the IOM are the impetus for many organizations moving towards the provision of TS/SCPs. Yet, empowering patients with knowledge to participate in their own surveillance, risk reduction, and wellness, and improving the continuum of care, should be the driving force for oncology providers in expanding the scope and practice of survivorship care. As the survivorship pool continues to grow, more research is needed to comprehensively address the unique and changing needs of the 21 st century cancer patient.
Disclosures:
The authors report no conflicts of interest in this work. In the project facility, dedicated survivorship care was absent and there was no TS/SCP in use.
Practice Innovation Process:
The John Hopkins Nursing Evidence-Based Practice Model was used to guide this project. At the chemotherapy teaching visit, the Medical Assistant documented the demographic information of the TS/SCP into the Journey Forward Care Plan Builder. Using the pathology report, chemotherapy orders, and oncology consultation, the NP developed the TS/SCP in preparation for a 50-minute NP/patient survivorship visit. A copy of the NCI publication: Facing Forward: Life After Cancer Treatment was reviewed and questions were addressed. Knowledge was measured pre and post visit using the Confidence in Survivorship Information tool (CSI) while satisfaction was measured using the Patient Satisfaction with Cancer Care (PSCC) tool. A copy of the TS/SCP was provided to the patient and mailed to the treatment team and PCP, whose satisfaction was surveyed. The project benchmark was for 80% of the participants to increase their knowledge and satisfaction with breast cancer survivorship care.
Outcomes: All of the 21 participants, or 100%, who participated in the practice innovation had improvement in confidence in knowledge. Specifically, knowledge of cancer diagnosis/treatment details improved from a mean average of 1.57 to 2.0 while knowledge of prevention, late/long-term effects, resources, and family risk for cancer increased from a mean average of 0.82 to 1.85. Similarly, satisfaction increased for 95% of participants. Of the 73% of providers who completed the survey, 84% agreed/strongly agreed with the elements of the survey.
Conclusions: TS/SCP delivered in the context of a dedicated survivorship visit with an NP consistently increases knowledge of all domains measured in the CSI tool. Satisfaction with the intervention was positive. As with many education and wellness interventions, the NP is uniquely qualified to support patients completing chemotherapy with curative intent as they transition to survivorship care. Furthermore, depending on payer mix, post treatment survivorship visits represent a potential revenue stream for a community-based oncology practice.
TRANSITION AFTER BREAST CANCER TREATMENT:
Implementing 
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Background
SURVIVORS-
• experience more chronic healt h problems/ co-morbidit ies t hen general populat ion 3 ,4 • report more t hen 2 5 problems, concerns, and needs af t er Tx 3 ,5 ,6 ,7 • are at risk f or receiving inadequat e healt hcare 4 ,8 • f eel unprepared f or end of t reat ment 4 ,6 ,7 • report high levels of st ress and anxiet y 3 ,4 ,6 ,9
Evidence
• Treat ment summaries/ care plans are f undament al t o nursing and medical care
• Research shows signif icant impact wit h t he use of int eract ive int ervent ions, writ t en inf ormat ion, and psychoeducat ion 1 0 ,1 1
• Qualit at ive research support s t he use of TS/ SCP 4 ,5 ,6 ,7 
CONFIDENCE IN SURVIVORSHIP INFORMATION

PRE-VISIT POST-VISIT
Results
• 2 6 providers were mailed surveys,1 9 were ret urned ( 7 3 %) • 8 4 % of providers agreed/ st rongly agreed wit h all element s of t he survey • 9 5 % of t he women rat ed sat isf act ion at 4 or bet t er • Improve knowledge and ease t ransit ion • Provide opport unit y f or NP t o educat e: healt hy behaviors, risk reduct ion, assess impact of t reat ment
• Engages PT in surveillance, risk reduct ion, wellness • Serves as a road map clearly def ining EBP guidelines f or f ollow-up care t o ent ire t eam
Conclusions
• TS/ SCP provide similar impact at t he end of TX as chemo t eaching does at t he beginning • Pat ient s need/ benef it f rom assessment , educat ion and goal set t ing at t his junct ure • TS/ SCP should be complet ed by t he principle providers • Survivorship care is pot ent ially revenue generat ing and can decrease healt hcare cost s
Next Steps
• Addit ion of adjuvant Colon Cancer by Summer 2 0 1 5 • Explore int egrat ed EMR syst ems: OnQ, Varian Equicare CS • Development of t imeline f or addit ion of all diagnoses in which adjuvant t reat ment is employed: Lymphoma, Lung, Prost at e…
